This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
March 20, 2013 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the introduction of a new Modular Rail System (MRS) for external fixation and deformity correction. This new treatment option highlights Smith & Nephew's increased investment in its extremities and limb restoration portfolio, and its commitment to advancing technology by working directly with surgeon inventors.
Designed to correct bone deformities, malunions, non-unions and limb length discrepancies, the MRS takes advantage of the body's ability to grow new bone tissue. Using a segmented, external rail and a series of half-pins, the system holds various bone segments in correct alignment while new bone tissue grows and matures. Because the rail system is modular, it can be lengthened or shortened to meet the size needs of a patient, and can be joined with components from Smith & Nephew's TAYLOR SPATIAL FRAME™ and ILIZAROV™ circular fixation devices. And, unlike most rail systems, this new system is able to span a patient's joint, allowing it to bend and function normally while the device is in place.
The surgeon expert behind the MRS concept is
Dror Paley, MD, of the Paley Advanced Limb Lengthening Institute at St. Mary's Medical Center in
West Palm Beach, Fla.
"Over the course of my 25-plus year career, I've tried many of the available rail systems on the market, none of which fully meet my needs," explains Dr. Paley. "Working with Smith & Nephew, I was able to design and develop a modular, multiplanar rail which can articulate across the hip, knee, ankle or elbow joints while allowing for lengthening and deformity correction."
"We're excited to introduce the Modular Rail System to our surgeon customers and their patients," says
Mark Waugh, Divisional Vice President for Smith & Nephew's Extremities and Limb Restoration business. "The new system joins our industry-leading suite of limb restoration and deformity correction products, which includes the TAYLOR SPATIAL FRAME external fixator."
The Modular Rail System will be among the new technologies Smith & Nephew will highlight at this year's American Academy of Orthopedic Surgeons annual meeting. Dr. Paley will present on the MRS at the Smith & Nephew booth (booth #1812) on
Wednesday, March 20, at
About Smith & NephewSmith & Nephew is a global medical technology business dedicated to helping improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith & Nephew has almost 10,500 employees and a presence in more than 90 countries. Annual sales in 2012 were more than
$4.1 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).
For more information about Smith & Nephew, please visit:
www.smith-nephew.comForward-looking Statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in integrating acquired businesses, and disruption that may result from changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations. Trademark of Smith & Nephew. Registered US Patent and Trademark Office.
SOURCE Smith & Nephew